Medina CD, Cortés LN, Vega GMT, Cruz LJ

Idioma: Español
Referencias bibliográficas: 22
Paginas: 22-25
Archivo PDF: 64.72 Kb.

RESUMEN

Se presenta el caso de un paciente del sexo masculino de 71 años de edad con diagnóstico de linfoma No Hodgkin difuso de células grandes con inmunofenotipo B, que presenta fiebre, leucocitosis y un cultivo positivo para Staphylococcus aureus, asociado a dermatosis diseminada a extremidades superiores e inferiores constituida por manchas eritematovioláceas. La biopsia reporta vasculitis leucocitoclástica. Se hace el diagnóstico de vasculitis cutánea asociada a sepsis.

REFERENCIAS (EN ESTE ARTÍCULO)

1. González-Gay MA, García-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729-49.

2. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. 1990; 33: 1065-1067.

3. Mader R, Keystone EC. Infections that cause vasculitis. Curr Opin Rheumatol 1992; 4: 35-38.

4. Doutre MS, Barete S, Ly S et al. Vasculitis cutáneas y cutaneosistémicas. Encycl Méd Chir. Dermatologie, 98-563-A-10. Editions Scientifiques et Médicales Elsevier SAS. Paris. 2004.

5. Balk RA. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon 2004; 50: 168-213.

6. Marik PE, Varon J. Sepsis: state of the art. Dis Mon 2001; 47: 465-532.

7. Balk RA. Severe sepsis and septic schock definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000; 16: 179-92.

8. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States, analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29:1303-10.

9. Pizzo PA. Current concepts: Fever in immunocompromised patients. N Engl J Med 1999; 341: 893-900.

10. Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001; 15: 457-82.

11. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001; 17: 531-70.

12. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit care Med 1998; 26: 2078-86.

13. Parrillo JE, Parker MM, Natanson C. Septic shock in humans: advances in understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227-42.

14. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 2004; 24: 403-18.

15. Menzies BE, Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immunol 1998; 66: 5994-8.

16. Hotchkiss RS, Karl IE. Endothelial cell apoptosis in sepsis: A case of habeas corpus? Crit Care Med 2004; 32: 901-2.

17. Hotchkiss RS, Tinsley KW, Swanson PE et al: Endothelial cell apoptosis in sepsis. Crit Care Med 2002; 30(5 Suppl): S225-8.

18. McReady N. Use of mneumonic to find cause of leukocytoclastic vasculitis: many possible causes. Skin Allergy News 2003; 34: 48.

19. Roane DW, Griger DR. An approach to diagnosis and initial management of systemic vasculitis. Am Fam Physician 1999; 60: 1421-30.

20. Lie JT. Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 1995; 21: 883-909.

21. Gibson LE. Cutaneous vasculitis update. Dermatol Clin 2001; 19: 603-15.

22. Hunder G. Vasculitis: diagnosis and therapy. Am J Med 1996; 100(2A): 37S-45S.